These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21946245)

  • 1. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
    Levine AM
    Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphomas.
    Batara JF; Grossman SA
    Curr Opin Neurol; 2003 Dec; 16(6):671-5. PubMed ID: 14624075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related primary central nervous system lymphoma.
    Kasamon YL; Ambinder RF
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):665-87, vi-vii. PubMed ID: 16083829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part B: Malignant lymphoma.
    Cheung TW
    Cancer Invest; 2004; 22(5):787-98. PubMed ID: 15581059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.
    Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM
    Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
    Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of primary central nervous system lymphoma.
    Deangelis LM
    Oncology (Williston Park); 1995 Jan; 9(1):63-71; discussion 71, 75-6, 78. PubMed ID: 7718442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the management of primary CNS lymphoma.
    Nasir S; DeAngelis LM
    Oncology (Williston Park); 2000 Feb; 14(2):228-34; discussion 237-42, 244. PubMed ID: 10736810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.